Futibatinib: second EMA approval for FGFR inhibitor in cholangiocarcinoma.
作者信息
Lamarca A, Vogel A
机构信息
Department of Medical Oncology - OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada; Medical Oncology, Margaret Cancer Centre, Toronto, Canada.
出版信息
ESMO Open. 2023 Dec;8(6):102049. doi: 10.1016/j.esmoop.2023.102049. Epub 2023 Nov 2.
Abstract
摘要
Zotero 插件